GSA Capital Partners’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-24,008
| Closed | -$101K | – | 1984 |
|
|
2018
Q3 | $101K | Sell |
24,008
-12,964
| -35% | -$54.5K | 0.01% | 1559 |
|
|
2018
Q2 | $143K | Buy |
+36,972
| New | +$143K | 0.01% | 1573 |
|
|
2016
Q2 | – | Sell |
-1,723
| Closed | -$113K | – | 2025 |
|
|
2016
Q1 | $113K | Buy |
+1,723
| New | +$113K | 0.01% | 1571 |
|
|
2015
Q3 | – | Sell |
-31,910
| Closed | -$3.1M | – | 2196 |
|
|
2015
Q2 | $3.1M | Buy |
31,910
+11,959
| +60% | +$1.16M | 0.12% | 162 |
|
|
2015
Q1 | $1.87M | Buy |
+19,951
| New | +$1.87M | 0.07% | 386 |
|
|
2014
Q4 | – | Sell |
-9,514
| Closed | -$657K | – | 2034 |
|
|
2014
Q3 | $657K | Buy |
9,514
+3,241
| +52% | +$224K | 0.03% | 759 |
|
|
2014
Q2 | $360K | Buy |
+6,273
| New | +$360K | 0.02% | 1329 |
|